Chester County News and Community Website
BERWYN, PA — Annovis Bio Inc. (NYSE American: ANVS), a clinical-stage drug platform company addressing Alzheimer’s disease (AD), Parkinson’s disease (PD) and other neurodegenerative diseases, announced it successfully completed the …
Read More
HARRISBURG, PA — The Department of Aging is reminding Pennsylvanians of the preventive measures necessary to avoid falls, particularly among older adults.
Read More
The U.S. Department of Health and Human Services (HHS), through the Health Resources and Services Administration (HRSA), is announcing assisted living facilities (ALFs) may now apply for funding under the …
Read More
HARRISBURG, PA — Department of Human Services (DHS) Secretary Teresa Miller and Department of Health (DOH) Secretary Dr. Rachel Levine announced that all assisted living residences, personal care homes, and …
Read More BERWYN, PA — Annovis Bio Inc. (NYSE American: ANVS), a clinical-stage drug platform company addressing Alzheimer’s disease (AD), Parkinson’s disease (PD) and other neurodegenerative diseases, is pleased to announce its …
Read More
HARRISBURG, PA — In the June 2020 report, Pennsylvania Department of Health nursing home surveyors conducted 269 inspections of nursing homes, including 238 complaint investigations during the COVID-19 pandemic. Of …
Read MorePAOLI, PA — State Reps. Melissa Shusterman, D-Chester/Montgomery, and Bridget Kosierowski, D-Lackawanna, commended the release of updated guidance by the Pennsylvania Department of Health and Human Services to loosen restrictions on …
Read More
HARRISBURG, PA — Pennsylvania Department of Human Services (DHS) Secretary Teresa Miller and the Jewish Healthcare Foundation recently provided an update on the Educational Support and Clinical Coaching Program (ESCCP), …
Read More BERWYN, PA — Annovis Bio Inc. (NYSE American: ANVS), a clinical-stage drug platform company addressing Alzheimer’s disease (AD), Parkinson’s disease (PD) and other neurodegenerative diseases, announced today that the protocol …
Read MoreBERWYN, PA — Annovis Bio Inc. (NYSE: ANVS), a clinical-stage drug platform company addressing Alzheimer’s, Parkinson’s and other neurodegenerative diseases, was issued a patent (US 10,383,851) in August 2019 for …
Read More